OppenheimerFunds’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$243K Sell
12,057
-691
-5% -$14K ﹤0.01% 1640
2018
Q4
$227K Sell
12,748
-3,189
-20% -$56.7K ﹤0.01% 1684
2018
Q3
$313K Buy
15,937
+2,468
+18% +$50.8K ﹤0.01% 1639
2018
Q2
$267K Buy
13,469
+3,486
+35% +$76.6K ﹤0.01% 1670
2018
Q1
$246K Buy
9,983
+1,298
+15% +$34.1K ﹤0.01% 1660
2017
Q4
$249K Buy
+8,685
New +$273K ﹤0.01% 1751

Other funds holding ACLS

OppenheimerFunds's ACLS Position: Q1 2019 in Review

OppenheimerFunds reduced its Axcelis (ACLS) stake by 5.4% in Q1 2019, selling an estimated $14K and leaving 12,057 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #1640.

OppenheimerFunds first reported a position in ACLS in Q4 2017 and has held it in 6 quarters since. The position peaked at $313K in Q3 2018. 147 funds tracked by Wall St. Rank hold ACLS as of Q1 2019.

  • OppenheimerFunds held 12,057 shares of Axcelis worth $243K as of Q1 2019.
  • OppenheimerFunds sold 691 Axcelis shares in Q1 2019, an estimated $14K.
  • Axcelis made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1640 holding.
  • OppenheimerFunds first reported a position in Axcelis in Q4 2017 and has held it in 6 quarters since.
  • OppenheimerFunds's Axcelis position peaked at $313K in Q3 2018.
  • 147 funds tracked by Wall St. Rank held Axcelis as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.